Patients with renal insufficiency may have increased serum troponins even in the absence of
clinically suspected acute myocardial ischemia. While cardiovascular disease is the most …

Background—The prognostic usefulness of troponin enzymes in end-stage renal disease
(ESRD) patients is controversial. To resolve this uncertainty of troponin as a prognostic tool …

Background—The prevalence and determinants of cardiac troponin T (cTnT) elevation in the
general population are unknown, and the significance of minimally increased cTnT remains …

The engineered cardiac patch (ECP) is a promising strategy to repair infarct myocardium
and restore the cardiac function. An ideal ECP should be able to mimic the primary attributes …

ContextCardiac troponin T (cTnT) and C-reactive protein (CRP) are prognostic markers in
acute coronary syndromes. However, for patients with end-stage renal disease (ESRD) the …

The cardiac troponins form part of the regulatory mechanism for muscle contraction. Specific
cardiac isoforms of cardiac troponin T and cardiac troponin I exist and commercially …

Background: Spurious increases in serum troponins, especially troponin T, have been
reported in patients with and without acute myocardial syndromes. Methods: We studied 78 …

Background: Clinicians face uncertainty about the prognostic value of troponin testing in
patients with chronic kidney disease (CKD) without suspected acute coronary syndrome …

A novel biodegradable electroactive polyurethane containing aniline pentamer (AP) was
blended with polycaprolactone (PCL). The prepared blend (PB) and PCL were further …

Background: Serum cardiac troponin concentrations are commonly increased in end-stage
renal disease (ESRD) in the absence of an acute coronary syndrome (ACS). The data on …